Abstract:The objective of this study was to assess the effect of orally administered Escherichia coli Nissle 1917 (EcN) on the jejunal health of weaned piglets that were unchallenged or challenged with porcine enterotoxigenic E. coli Abbottstown (EcA). A total of 40 weaned Landrace×Yorkshire piglets (5.83±0.24kg) were allocated to 4 groups with 10 barrows per group, following a 2×2 factorial design with 2 inclusion levels of EcN (daily oral administration of 2mL sterile water or 2mL EcN (109cells/mL)) at 10:00h) and 2 inclusion levels of EcA (daily oral administration of 2mL sterile water or 2mL EcA (109cells/mL) at 14:00h). Thus, there were four treatments: (1) control diet (C); (2) C+EcN (N); (3) C+EcA (A); (4) C+EcN+EcA (N+A). This experiment lasted for 21 d. The results indicated a significant interaction between EcN and EcA on growth performance and jejunal mucosal membrane integrity, morphology, immune parameters and the antioxidant capacity in 21-day-weaned piglets (P<0.05). The results that piglets in the A group had lowest feed conversion, daily weight gain, daily feed intake, jejunal villus height (P<0.05) among the 4 groups suggested that the oral administration of EcA decreased growth performance. The results that piglets in the A group had lowest mRNA levels of regenerating islet derived protein 3 gamma and transforming growth factor beta 1 (P<0.05), lowest protein levels of claudin-1, occludin, and zonula occludens-1 (P<0.05) and highest serum d-lactate concentration (P<0.05) among the 4 groups suggested that the oral administration of EcA damaged jejunal mucosal membrane integrity. The immune and antioxdant parameters results that orally administered EcA increased mRNA levels of interleukin (IL)-1β, IL-8, tumor necrosis factor (TNF)-α, and toll-like receptor (TLR) -4 (P<0.05), increased the concentrations of IgM, IgG, IL-1β, TNF-α, sIgA (P<0.05), and TLR-4, and decreased activities of superoxide dismutase and total antioxidant (P<0.05) suggested that EcA could make the jejunal mucosal membrane inflamed in early weaned piglets. Orally administered EcN tended to improved growth performance, jejunal villus height, the immune and antioxdant function, jejunal mucosal membrane integrity in piglet unchallenged or challenged with EcA. This improvement of the jejunal health and growth performance of piglets challenged with EcA by oral administration of EcN could be attributed to increased defense against harmful bacteria and improved epithelial barrier function. These results demonstrated that EcN could be used in early-weaned piglets to prevent intestinal infection by the pathogenic bacteria EcA.

Multiple effects of Escherichia coli Nissle 1917 on growth, biofilm formation, and inflammation cytokines profile of Clostridium perfringens type A strain CP4

Effects of a Probiotic, Enterococcus Faecium, on Growth Performance, Intestinal Morphology, Immune Response, and Cecal Microflora in Broiler Chickens Challenged with Escherichia Coli K88

Effector responses of bovine blood neutrophils against Escherichia coli : Role of NOD1/NF-κB signalling pathway

Effect of Probiotic E. coli Nissle 1917 Supplementation on the Growth Performance, Immune Responses, Intestinal Morphology, and Gut Microbes of Campylobacter jejuni Infected Chickens

Escherichia Coli Nissle 1917 Protects Intestinal Barrier Function by Inhibiting NF-κB-Mediated Activation of the MLCK-P-MLC Signaling Pathway.

Probiotic Escherichia coli Nissle 1917 reduces growth, Shiga toxin expression, release and thus cytotoxicity of enterohemorrhagic Escherichia coli

Comprehensive Analysis of the Physiological Characterization of Escherichia coli Nissle 1917

Probiotics Escherichia Coli Nissle 1917: Stress Resistance, Swine Intestinal Epithelial Cell Adhesion Rate and Antimicrobial Effects

Probiotic Escherichia coli Nissle 1917 and Commensal E. coli K12 Differentially Affect the Inflammasome in Intestinal Epithelial Cells

Enterococcus faecium inhibits NF-κB/NLRP3/Caspase-1 signaling pathway to antagonize enterotoxigenic Escherichia coli-mediated inflammatory response

P1213 The effects of Escherichia coli Nissle 1917 on the gut microbiota composition in ulcerative colitis patients

Escherichia coli Nissle 1917 Protects against Sepsis-Induced Intestinal Damage by Regulating the SCFA/GPRs Signaling Pathway

Effects of dietary Nisin on growth performance, immune function, and gut health of broilers challenged by Clostridium perfringens

Encapsulation of Escherichia coli strain Nissle 1917 in a chitosan-alginate matrix by combining layer-by-layer assembly with CaCl2 cross-linking for an effective treatment of inflammatory bowel diseases

Antibacterial MccM as the Major Microcin in Escherichia coli Nissle 1917 against Pathogenic Enterobacteria

Probiotic Escherichia coli NISSLE 1917 for inflammatory bowel disease applications.

Effects of Orally Administered Escherichia Coli Nissle 1917 on Growth Performance and Jejunal Mucosal Membrane Integrity, Morphology, Immune Parameters and Antioxidant Capacity in Early Weaned Piglets

Protective Effect of Escherichia Coli Nissle 1917 on Salmonella Typhimurium Infection by Regulating Intestinal Microbiota in Mice

Escherichia coli Nissle 1917 Antagonizes Candida albicans Growth and Protects Intestinal Cells from C. albicans-Mediated Damage

Expectations for employing Escherichia coli Nissle 1917 in food science and nutrition

The Effect of Caco-2 Cells on Sporulation and Enterotoxin Expression by Foodborne Clostridium perfringens